Abstract

Emerging evidence has shown that microRNAs have key roles in regulating various normal physiological processes, whereas their deregulated expression is correlated with various diseases. The miR-146 family includes miR-146a and miR-146b, with a distinct expression spectrum in different hematopoietic cells. Recent work indicated that miR-146a has a close relationship with inflammation and autoimmune diseases. miR-146-deficient mice have developed some abnormal hematopoietic phenotypes, suggesting the potential functions of miR-146 in hematopoietic development. In this study, we found that miR-146b was consistently up-regulated in both K562 and CD34(+) hematopoietic stem/progenitor cells (HSPCs) undergoing either erythroid or megakaryocytic differentiation. Remarkably, erythroid and megakaryocytic maturation of K562 cells was induced by excess miR-146b but inhibited by decreased miR-146b levels. More importantly, an mRNA encoding receptor tyrosine kinase, namely platelet-derived growth factor receptor α (PDGFRA), was identified and validated as a direct target of miR-146b in hematopoietic cells. Gain-of-function and loss-of-function assays showed that PDGFRA functioned as a negative regulator in erythroid and megakaryocytic differentiation. miR-146b could ultimately affect the expression of the GATA-1 gene, which is regulated by HEY1 (Hairy/enhancer-of-split related with YRPW motif protein 1), a transcriptional repressor, via inhibition of the PDGFRA/JNK/JUN/HEY1 pathway. Lentivirus-mediated gene transfer also demonstrated that the overexpression of miR-146b promoted erythropoiesis and megakaryocytopoiesis of HSPCs via its regulation on the PDGFRA gene and effects on GATA-1 expression. Moreover, we confirmed that the binding of GATA-1 to the miR-146b promoter and induction of miR-146b during hematopoietic maturation were dependent on GATA-1. Therefore, miR-146b, PDGFRA, and GATA-1 formed a regulatory circuit to promote erythroid and megakaryocytic differentiation.

Highlights

  • MicroRNA-146-deficient mice have developed some abnormal hematopoietic phenotypes

  • Gain-of-function and loss-offunction assays showed that PDGFRA functioned as a negative regulator in erythroid and megakaryocytic differentiation. miR146b could affect the expression of the GATA-binding protein 1 (GATA-1) gene, which is regulated by HEY1 (Hairy/enhancer-of-split related with YRPW motif protein 1), a transcriptional repressor, via inhibition of the PDGFRA/JNK/JUN/HEY1 pathway

  • Fluorescence-activated cell sorting (FACS) analysis using a major erythroid cell surface marker (CD235a) showed that excess miR-146b increased the percentage of CD235aϩ cells (ϳ8% at 24 h, 11% at 48 h, and 9% at 72 h after hemin induction) compared with cells transfected with the scrambled control (Fig. 1D)

Read more

Summary

Background

Results: MicroRNA-146b-5p (miR-146b), transcriptionally activated by GATA-binding protein 1 (GATA-1), promotes human erythroid and megakaryocytic differentiation via regulating the PDGFRA signaling pathway. Conclusion: A regulatory circuit comprising miR-146b, PDGFRA, and GATA-1 promotes erythroid and megakaryocytic differentiation. We found that miR-146b was consistently up-regulated in both K562 and CD34؉ hematopoietic stem/progenitor cells (HSPCs) undergoing either erythroid or megakaryocytic differentiation. Erythroid and megakaryocytic maturation of K562 cells was induced by excess miR-146b but inhibited by decreased miR146b levels. We demonstrated that PDGFRA could function as a negative regulator in erythroid and megakaryocytic differentiation. MiR-146b, PDGFRA, and GATA-1 formed a regulatory circuit to promote erythroid and megakaryocytic differentiation

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.